Sign in
CompletedNo phase

Predicting 28-Day Survival in OHCA Patients

Key facts

Who runs it
Haseki Training and Research Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
327 people enrolled
Started
1 May 2023
Ended
1 Jun 2024
Type of study
Observational, 2 groups
Treatments tested
  • Demographics
  • Comorbidities
  • Prehospital Variables
  • Hematological Parameters
  • Biochemical Parameters
  • Arterial Blood Gas Parameters
Record updated
15 June 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • This study included 420 adult patients (aged ≥18 years) who were brought to our hospital's ED due to OHCA and who had initiated attempted resuscitation by EMS were initially screened for inclusion between May 2023 and May 2024

Who cannot take part

  • Patients with in-hospital cardiac arrest
  • Patients who have suffered cardiac arrest due to major trauma, drowning, drug overdose, or known terminal illness
  • Patients with active hematologic malignancy
  • Patients with incomplete data regarding primary outcomes or admission laboratory tests
  • Patients aged < 18 years

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective study aimed to identify clinical and laboratory predictors of return of spontaneous circulation (ROSC), 28-day survival, and favorable neurological outcomes in adult patients experiencing out-of-hospital cardiac arrest (OHCA) and brought to the emergency department (ED) by emergency medical services (EMS). Specifically, the prognostic value of hematologic, biochemical, and blood gas parameters on admission was assessed for ROSC, 28-day survival, and favorable neurological recovery. Additionally, the study investigated the influence of key patient-centered and prehospital variables, including demographic features, initial cardiac rhythm, and the timeliness and type of cardiopulmonary resuscitation (CPR), defibrillation, and airway interventions, on overall survival and neurological status.

The 2 groups in the trial

  • Survivors

    Survivors were defined as the patient being alive at 28 days following the cardiac arrest event.

    Treatment: Demographics, Comorbidities, Prehospital Variables, Hematological Parameters, Biochemical Parameters, and Arterial Blood Gas Parameters

  • Non-survivors

    Non-survivors had passed away within 28 days following the cardiac arrest event.

    Treatment: Demographics, Comorbidities, Prehospital Variables, Hematological Parameters, Biochemical Parameters, and Arterial Blood Gas Parameters

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Predicting Clinical Factors and Laboratory Parameters Associated With Short-Term Survival in Out-of-Hospital Cardiac Arrest
Record updated
15 June 2025